Tandem’s t:slim X2 Insulin Pump Now Integrates with Abbott’s FreeStyle Libre 3 Plus Sensor

Editorial Team
2 Min Read


What You Ought to Know: 

Tandem Diabetes Care, an insulin supply and diabetes know-how firm, as we speak introduced that its Tandem t:slim X2™ insulin pump with Management-IQ+ automated insulin supply (AID) know-how now works with Abbott’s FreeStyle Libre® 3 Plus steady glucose monitoring (CGM) sensor.

– The corporate has initiated an early entry program in america and intends to scale availability within the second half of 2025. 

Increasing Affected person Alternative and Personalization

This new integration addresses a crucial want for personalization in diabetes care. By connecting two main applied sciences, extra folks dwelling with diabetes can entry the advantages of a sophisticated AID system. The newly built-in system combines the strengths of each Tandem’s and Abbott’s flagship merchandise to create a seamless consumer expertise.

  • Abbott’s FreeStyle Libre 3 Plus Sensor: This CGM options an prolonged 15-day put on time and transmits computerized glucose readings each minute on to the t:slim X2 pump. Customers also can view their knowledge on the Tandem t:slim cellular app for added comfort.
  • Tandem’s t:slim X2 with Management-IQ+: This superior hybrid closed-loop algorithm adjusts insulin each 5 minutes primarily based on predicted glucose values. It’s the solely system with the distinctive AutoBolus™ function, which mechanically calculates and delivers a correction bolus to assist with missed meal boluses.

A International Technique for Expanded Entry

This launch is step one in a broader technique to attach Tandem’s portfolio of insulin pumps with Abbott’s FreeStyle Libre sensors worldwide. Tandem will e-mail eligible customers within the U.S. with extra data on how one can entry the brand new integration when it turns into accessible.

“That is an thrilling first step in our technique to attach Tandem’s portfolio of insulin pumps to Abbott’s FreeStyle Libre 3 Plus sensors worldwide,” mentioned John Sheridan, president and chief govt officer of Tandem Diabetes Care. “We sit up for increasing entry to our t:slim X2 customers exterior of the U.S. starting later this 12 months.”

Share This Article